Random-effects models showed that mTOR inhibitors were significantly associatedwith reduced mortality (OR=0.63, 95% CI 0.48-0.83, P=0.001) but not with COVID-19 severity (OR=0.70, 95% CI 0.41-1.20, P=0.865). The gene discussed is MTOR; the disease is COVID-19.